Large-artery stiffness: A reversible marker of cardiovascular risk in primary hyperparathyroidism

Atherosclerosis

Volumn 218, Issue 1, 2011, Pages 96-101

  Schillaci, Giuseppe ^a   Pucci, Giacomo ^a   Pirro, Matteo ^a   Monacelli, Massimo ^a   Scarponi, Anna Maria ^a   Manfredelli, Maria Rosaria ^a   Rondelli, Fabio ^a   Avenia, Nicola ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Arterial stiffness; Parathyroidectomy; Primary hyperparathyroidism; Pulse wave velocity

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; ARTICLE; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FEMORAL ARTERY; HIGH RISK PATIENT; HUMAN; MALE; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; TONOMETRY;

AGED; AORTA; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROIDECTOMY; REGRESSION ANALYSIS; RISK; SAMPLE SIZE; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 80052271812     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.010     Document Type: Article

References (35)

1. Cormier C., Souberbielle J.-C., Kahan A. Primary hyperparathyroidism and osteoporosis in 2004. Joint Bone Spine 2004, 71:183-189.
2. Hedbäck G., Odén A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest 1998, 28:277-278.
3. Wermers R.A., Khosla S., Atkinson E.J., et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 1998, 2:115-122.
4. Lundgren E., Lind L., Palmér M., et al. Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery 2001, 130:978-985.
5. Hagström E., Hellman P., Larsson T.E., et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009, 119:2765-2771.
6. Mitchell G.F., Hwang S.J., Vasan R.S., et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121:505-511.
7. Laurent S., Katsahian S., Fassot C., et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34:1203-1206.
8. Blacher J., Safar M.E., Guerin A.P., et al. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003, 63:1852-1860.
9. Bitigen A., Tanalp A.C., Kaynak E., et al. Elastic properties of aorta in patients with primary hyperparathyroidism. Int J Clin Pract 2006, 60:1572-1575.
10. Smith J.C., Page M.D., John R., et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85:3515-3519.
11. Rubin M.R., Maurer M.S., McMahon D.J., Bilezikian J.P., Silvenberg S.J. Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90:3326-3330.
12. Kosch M., Hausberg M., Barenbrock M., et al. Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy. Clin Nephrol 2001, 55:303-308.
13. Barletta G., De Feo M.L., Del Bene R., et al. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85:1815-1821.
14. Tordjman K.M., Yaron M., Izkhakov E., et al. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol 2010, 162:925-933.
15. Stefenelli T., Mayr H., Bergler-Klein J., et al. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993, 95:197-202.
16. Hedbäck G., Tisell L.-E., Odén A. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991, 15:399-407.
17. Breslow N.E., Lubin J.H., Marek P., Langholz B. Multiplicative models and cohort analysis. J Am Stat Assoc 1983, 78:1-12.
18. Bilezikian J.P., Potts J.T., Fuleihan G.-H., et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002, 87:5353-5361.
19. Schillaci G., De Socio G.V., Pirro M., et al. Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. Arterioscler Thromb Vasc Biol 2005, 25:2381-2385.
20. Schillaci G., Pirro M., Mannarino M.R., et al. Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension 2006, 48:616-621.
21. Pirro M., Schillaci G., Paltriccia R., et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006, 26:2530-2535.
22. Rosner B. A generalization of the paired t-test. Appl Stat 1982, 31:9-13.
23. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
24. Laurent S., Cockcroft J., Van Bortel L., et al. European network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
25. Barenbrock M., Hausberg M., Kosch M., et al. Effect of hyperparathyroidism on arterial distensibility in renal transplant patients. Kidney Int 1998, 54:210-215.
26. Nilsson I.L., Aberg J., Rasted J., Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999, 129:1049-1055.
27. Rosa J., Raska I., Wichterle D., et al. Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. Hypertens Res 2011 Mar, 34:296-300.
28. Roberts W.C., Waller B.F. Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med 1981, 71:371-384.
29. LeBeouf A., Mac-Way F., Utescu M.S., et al. Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant 2009, 24:3788-3794.
30. Song G.J., Fiaschi-Taesch N., Bisello A. Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells. Mol Endocrinol 2009, 23:1681-1690.
31. Perkovic V., Hewitson T.D., Kelynack K.J., et al. Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 2003, 26:27-33.
32. Rashid G., Bernheim J., Green J., Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 2007, 292:F1215-F1218.
33. Rashid G., Plotkin E., Klein O., et al. Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C. Am J Physiol Renal Physiol 2009, 296:F60-F66.
34. Cecelja M., Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009, 54:1328-1336.
35. van der Heijden-Spek J.J., Staessen J.A., Fagard R.H., et al. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 2000, 35:637-642.